The iconic supermodel graced the cover of British Vogue’s September issue, with an accompanying profile by deputy editor Sarah Harris. In the story, Evangelista opened up about her slow reemergence into the public eye after announcing in September 2021 that she had developed paradoxical adipose hyperplasia as a result of CoolSculpting treatment. The condition is a rare side effect of the procedure in which fat cells grow instead of decreasing as intended. She also discussed her decision to seek out CoolSculpting initially, as well as her life and career today.
”Those CoolSculpting commercials were on all the time, on CNN, on MSNBC, over and over, and they would ask, ‘Do you like what you see in the mirror?’ They were speaking to me. It was about stubborn fat in areas that wouldn’t budge. It said no downtime, no surgery and … I drank the magic potion, and I would because I’m a little vain,” she said. “So I went for it – and it backfired.”
When Evangelista first spoke about her experience last September, she announced that she had filed a lawsuit against CoolSculpting’s parent company Zeltiq, which is owned by pharmaceutical conglomerate Allergan. The lawsuit has since been settled. Since September 2021, Evangelista has starred in a Fendi campaign in July and appeared on the cover of People magazine in February.
